Lv2
170 积分 2024-04-26 加入
T cell costimulatory blockade ameliorates induction of experimental membranous nephropathy potentially through T-helper 17 cell suppression in the kidney
1天前
求助中
Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy
16天前
已完结
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
3个月前
已完结
B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges
4个月前
已完结
Treating primary membranous nephropathy with extremely high titer of anti-phospholipase A2 receptor antibodies: A case of failed treatment with very high-dose rituximab
4个月前
已关闭
Comparison of obinutuzumab and rituximab for treating primary membranous nephropathy
5个月前
已完结
A novel approach to induce early remission in high-risk primary membranous nephropathy
5个月前
已完结
Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy
8个月前
已完结
Combined Serologic and Genetic Risk Score and Prognostication of PLA2R-Associated Membranous Nephropathy
9个月前
已完结
皖公网安备34019202002308
